• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
COVID-19: Pregnancy
CMECNE

Managing an Obstetric Office Practice During COVID-19

image_pdfFavoriteLoadingFavorite

Learning Objectives and CME/Disclosure Information

This activity is intended for healthcare providers delivering care to women and their families.

After completing this activity, the participant should be better able to:

1. Discuss changes to consider in the traditional prenatal visit schedule to reduce risk of COVID-19 exposure
2. Describe key points to consider with respect to fetal assessment in the setting of the COVID-19 pandemic

Estimated time to complete activity: 0.25 hours

Faculty:

Susan J. Gross, MD, FRCSC, FACOG, FACMG
President and CEO, The ObG Project

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


The PIM planners and others have nothing to disclose. The OBG Project planners and others have nothing to disclose.

Faculty: Susan J. Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc.

Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Method of Participation and Request for Credit

Fees for participating and receiving CME credit for this activity are as posted on The ObG Project website. During the period from 03-23-2020 through 03-23-2021, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the test and evaluation. Upon registering and successfully completing the test with a score of 100% and the activity evaluation, your certificate will be made available immediately.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The ObG Project. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.25 contact hours.

Read Disclaimer & Fine Print

NOTE: Information and guidelines may change rapidly. Check in with listed references in ‘Learn More – Primary Sources’ to best keep up to date

SUMMARY:

Boelig et al. (AJOG MFM, 2020) provide a helpful (and necessary) overview, including suggestions for managing obstetrical workflows during the COVID-19 pandemic. The focus is not only on MFM practice; the authors also provide multiple proposals that may ease congestion and limit viral spread. Note that the following summary reflects ‘Expert Review’. Professional society and organization COVID-19 guidelines may differ.


  • Patient with Symptoms
  • Altering the Standard OB Visit Schedule
  • Prenatal Ultrasound
  • NSTs and BPPs

Patient with Symptoms

  • Pregnancy alone warrants testing (if influenza negative)
    • “Especially if additional risk factors”
  • Triage via telehealth to determine if additional supportive care is required
    • Mild symptoms do not require in-person assessment
    • Self-isolate for 14 days (i.e., assume infection unless confirmed otherwise)
    • Use drive-through testing or stand-alone testing rather than in-person office visits/testing
  • If patient does come to the office and is symptomatic, assume infection | CDC recommends that

Patients with suspected or confirmed COVID-19 should be asked to wear a surgical mask as soon as they are identified and be evaluated in a private room with the door closed

Healthcare personnel entering the room should use Standard and Transmission-based Precautions

Altering the Standard OB Visit Schedule

Visits Without Face-to-Face Interactions

  • Intake Visit
    • Can be done by telehealth unless urgency to visit
    • In general, the authors recommend taking advantage of telehealth opportunities if possible
  • 16, 24 and 34 weeks
    • Use telehealth
  • Postpartum
    • Photos can be used to assess wounds and other issues (e.g., mastitis) and uploaded via patient portals

In-Person Antenatal Visit Schedule

  • <11 weeks
    • Telephone OB intake
    • Consider earlier if at risk for ectopic
  • 11-13 weeks
    • Ultrasound for dating and aneuploidy screening (if not scanned previously | If proven viability, cfDNA (NIPS) could obviate need for ultrasound
    • OB labs
  • 20 weeks
    • Structural fetal anatomy ultrasound
  • 28 weeks
    • Appropriate labs (e.g., GDM screening) and vaccines
  • 32 weeks
    • Ultrasound (if indicated)
  • 36 weeks
    • Ultrasound (if indicated)
    • GBS/HIV screen
  • 37 weeks until delivery
    • Weekly visits

Additional Considerations

  • Use home BP monitoring where possible
  • Use low volume blood drawing centers if feasible

KEY POINTS

  • The authors provide some general points and suggested abbreviated visit schedules for ultrasound and fetal assessment to limit exposure and protect the health of patients and obstetric professionals
  • MFM practices and obstetrical units may alter their routine scheduling patterns for high risk OB patients based on resources and local policies | The authors’ modified schedules can be found in ‘Learn More – Primary Sources’ below

Prenatal Ultrasound

  • Dating
    • cfDNA is an option for aneuploidy testing if patient has had an early first trimester ultrasound and viability is established
  • Anatomy (Early 2nd trimester to 22 weeks)
    • Consider limiting follow-up views to 4 to 8 weeks vs usual 1 to 2 weeks
    • If only a single view or 2 views are missing (example given: lumbar sacral spine not well seen but posterior fossa is within normal, which would strongly suggest absence of NTD)
    • BMI>40: Schedule later in pregnancy (e.g., 22 weeks) to avoid need for follow up due to missing views
  • Additional ultrasound testing
    • Third trimester growth scan: 32 weeks
    • previa/low lying placenta: 34-36 weeks
  • Authors suggest using telehealth for ultrasound counseling where possible, especially in the absence of a new onset finding

NSTs and BPPs

  • Authors suggest minimizing NST visits or using alternative fetal assessment methods where possible
    • NSTs 2x per week should be limited to IUGR with abnormal Doppler flows
    • NSTs initiated <32 weeks should be avoided when possible
    • Avoid NST and use BPP if a patient is already undergoing an ultrasound assessment
  • Kick counts
    • Consider as an alternative to NST in lower risk patients, such as
      • Women age 35 to 39
      • BMI>40 (uncomplicated)
  • Gestational hypertension or preeclampsia
    • Weekly office visit and daily home blood pressure monitoring

Learn More – Primary Sources:

MFM Guidance for COVID-19 (Boelig et al. AJOG MFM, 2020)

CDC: Healthcare Professionals Frequently Asked Questions and Answers

SMFM: COVID-19 in Pregnancy: Preparing your Obstetrical Units

ISUOG Webinar: How to prepare your unit for Coronavirus

Social Distancing for Outpatient OB Ultrasonographers and Nurses

Take a post-test and get CME credits

TAKE THE POST TEST

Get Guideline Notifications direct to your phone with ObGFirst

Try it Free »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19: Pregnancy Posts
Next >

Related ObG Topics:

Coronavirus and Pregnancy: CDC Guidance and Professional Recommendations
ARDS, Critical Care and COVID-19: ‘Surviving Sepsis Campaign’ Guidelines and Key Points
COVID-19: Category Definitions, Symptoms and Those at Increased Risk
ACOG COVID-19 FAQs for Obstetrical Care

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site